Peptides International

Peptides International Inc., a privately held biotech company, announced today a change in its executive management. At a recent meeting of the Company, owner Jackie B. Spatola indicated that Dr.

With all the news and concern about the Zika virus pandemic currently developing, Peptides International is pleased to announce that the company has added five new Zika virus proteins to its recombinant protein catalog offerings.

Hepcidin-Murine Compete™ ELISA Kit is available now and other novel hepcidin ELISA kits are in development

Peptides International Inc., a privately held biotech company, is proud to report that Dalazatide (formerly known as ShK-186), a venom-derived peptide from a sea anemone similar to Stichodactyla Toxin (ShK) (Amide) licensed to the biotechnology company...

Louisville, KY – February 10th, 2015 – Peptides International Inc., a privately held biotech company, announced today the release of the latest version of its website, PEPNET.COM.

Nearly Five Thousand Unique Products Will Be Available Worldwide

A Unique and Useful Application to Drug Discovery Researchers

Louisville, KY –  Peptides International Inc., is celebrating its thirtieth year as a manufacturer and distributor of peptides and peptide research related products and services. The late Professor Arno F.

Broad Research Collection of Drug Discovery Tools Released, Includes Exclusive Distribution Agreement

The company is the only participating biotechnology company.